A Phase 2b, prospective, open-label trial evaluating the efficacy, safety, and pharmacokinetics ofremimazolam for intravenous sedation in paediatric patients undergoing diagnostic and/or therapeuticprocedures.

Project: Research project

Project Details

Description

A Phase 2b, prospective, open-label trial evaluating the efficacy, safety, and pharmacokinetics of remimazolam for intravenous sedation in paediatric patients undergoing diagnostic and/or therapeutic procedures.
StatusActive
Effective start/end date8/15/218/12/22

Funding

  • PAION

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.